Graves Light Private Wealth Management Inc. increased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,995 shares of the healthcare conglomerate’s stock after purchasing an additional 47 shares during the quarter. Graves Light Private Wealth Management Inc.’s holdings in UnitedHealth Group were worth $487,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of UNH. Eastern Bank boosted its stake in UnitedHealth Group by 2.0% in the 2nd quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after buying an additional 1,375 shares during the last quarter. Enterprise Bank & Trust Co acquired a new stake in UnitedHealth Group in the 1st quarter worth about $3,785,000. Private Advisors LLC boosted its stake in UnitedHealth Group by 57.9% in the 1st quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock worth $1,607,000 after buying an additional 2,385 shares during the last quarter. First City Capital Management Inc. acquired a new stake in UnitedHealth Group in the 4th quarter worth about $580,000. Finally, Capital Investment Advisors LLC boosted its stake in UnitedHealth Group by 26.2% in the 2nd quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock worth $1,556,000 after buying an additional 1,323 shares during the last quarter. Hedge funds and other institutional investors own 85.87% of the company’s stock.
A number of brokerages have issued reports on UNH. UBS Group began coverage on UnitedHealth Group in a research note on Tuesday, April 23rd. They issued a “neutral” rating and a $238.00 price target on the stock. SunTrust Banks decreased their price target on UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research note on Wednesday, April 17th. They noted that the move was a valuation call. Royal Bank of Canada set a $311.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. ValuEngine lowered UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, April 18th. Finally, Barclays decreased their price target on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 17th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $295.06.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the consensus estimate of $3.46 by $0.14. The business had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company’s revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the company posted $3.14 EPS. On average, equities analysts expect that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.
In related news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $239.02, for a total transaction of $1,195,100.00. Following the sale, the director now directly owns 77,993 shares in the company, valued at approximately $18,641,886.86. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total value of $2,419,900.00. Following the sale, the director now owns 187,663 shares in the company, valued at $45,412,569.37. The disclosure for this sale can be found here. Insiders sold a total of 37,000 shares of company stock worth $9,158,720 over the last ninety days. Corporate insiders own 0.87% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: What does relative strength index mean?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.